Search All News
Cancer patients are especially vulnerable to COVID and would benefit from the protection the vaccine offers, says Gary Schwartz, MD, deputy director of the Herbert Irving Comprehensive Cancer Center.
A new analysis of almost 10,000 patients found that tumors could be stratified into 112 subtypes regardless of the cancer’s origin.
A new study has found that up to 20% of aggressive brain cancers are fueled by overactive mitochondria and new drugs in development may be able to starve the cancers.
- December 16, 2016
Researchers have found that blocking nerve growth factor inhibits the formation of stomach cancers, according to a study in mice.
- December 5, 2016
In a phase 1 study, eight out of 12 patients with relapsed and/or refractory blood cancers responded to a combination of two common chemotherapy drugs.
- September 14, 2016
In mice studies, targeting the SET protein revives p53, a potent tumor suppressor, and prevents cancer growth.
- July 21, 2016
Adding a new drug called olaratumab to traditional chemotherapy increased survival in sarcoma patients, researchers at Columbia University Medical Center have found.
- July 15, 2016
The three-dimensional structure could help researchers develop novel therapies and diagnostic tools for diseases that are caused by a malfunction in calcium adsorption.
- July 12, 2016
According to a new report published in JAMA Oncology, women with BRCA1 mutations have a higher risk of developing an aggressive type of uterine cancer.
- July 8, 2016
$4 million grant gives Columbia, Weill Cornell Medicine, NewYork-Presbyterian, and NYC Health + Hospitals key role in precision medicine cohort program.
- July 1, 2016
CUMC, NYP, and Weill Cornell are participating in a care delivery model that supports and encourages higher quality, more coordinated cancer care.